Comparing the current results to its competitors, Milestone Scientific Inc reported Revenue decrease in the 1 quarter 2026 year on year by -3.15 %, despite the revenue increase by the most of its competitors of 3.84 %, recorded in the same quarter.
Milestone Scientific Inc , slower than the average decrease reported by the company's competitors of -0.38 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -0.38 %
Milestone Scientific Inc 's Comment on Competition and Industry Peers
Milestone Scientific operates in a competitive environment where developments by other companies may render its products or technologies obsolete or non-competitive. Changes in United States international trade policies, including tariffs and export controls on goods imported from China and other countries, have resulted in retaliatory tariffs and trade measures by China, the United States, and other nations. These changes may increase costs for Milestone Scientific, which could adversely affect its results of operations.
July 23, 2024
Milestone Scientific Expands Market Presence with Medicare Price Assignment and Direct Sales InitiativesMilestone Scientific, a leading developer of computerized drug delivery instruments specializing in painless and precise injections, announced two significant developments that are set to bolster its market presence and drive growth. The company has secured a Medicare Part B Physician payment rate for its CompuFlo Epidural System and has also commenced direct sales of its STA Single Tooth Anesthesia System through a partnership with Meridian Endo and Perio.The Medicare price assignment for the CompuFlo Epidural System marks a major breakthrough for Milestone Scientific. Novitas Solutions, Inc., a Jurisdict...
February 20, 2024
Milestone Scientific Expands Direct Sales of Innovative Dental Anesthesia Systems to Premier Northeast Group Practice and Spanish MarketROSELAND, N.J., Feb. 20, 2024 - Milestone Scientific Inc. (NYSE:MLSS), a renowned pioneer in the development of state-of-the-art computerized drug delivery instruments that provide painless and precise injections, continues to make significant strides in the healthcare industry. The company has recently commenced direct sales of its breakthrough STA Single Tooth Anesthesia System (STA) to Maine Dental Group, a premier group of 21 dental practices across the northeastern region of the United States. In addition, Milestone Scientific has entered into an agreement with Bioline ...
December 8, 2023
Milestone Scientific s CompuFlo Disposables Revolutionize Neurostimulation Spinal Cord Implantation Procedures with 100% Success Rate Milestone Scientific Inc. recently announced the commencement of sales for its innovative CompuFlo Disposables, designed specifically for use in neurostimulation spinal cord implantation procedures. The technology has gained widespread recognition and adoption at UTMB Health Clear Lake Campus Hospital, following a successful evaluation process in which it achieved a remarkable 100% success rate. This achievement solidifies Milestone Scientific s position as a leading provider of cutting-edge medical devices and highlights the significant impact of its innovative solutions ...
Milestone Scientific Inc. (NYSE: MLSS), a prominent developer of computerized drug delivery instruments specializing in painless and precise injections, has recently announced a partnership with Bioline Supply for the distribution of its CompuFlo Epidural System and related disposables in Spain. Bioline Supply, a leading distributor of medical devices and equipment, will support the introduction of Milestone Scientific s innovative pain management solutions across numerous hospitals and pain clinics in Spain. This strategic agreement marks an important milestone for Milestone Scientific as it expands its reach into the Spanish market. Distributing Cutting-Edge Solutions: The CompuFlo Epidur...
Becton Dickinson and Company operates a business model focused on developing and providing advanced medical technologies, including a diverse portfolio of medical devices and diagnostic products. Their strategy emphasizes innovation, quality, and strategic partnerships to enhance patient care and streamline healthcare processes across various settings.
Patterson Companies Inc's business model focuses on distributing and selling a wide range of products and solutions to various industries, including dental, animal health, and rehabilitation.
Steris Plc operates in the healthcare industry by providing comprehensive infection prevention, decontamination, surgical, and critical care solutions designed for healthcare providers, including hospitals and pharmaceutical manufacturers. Their business model focuses on delivering a diverse array of innovative products, services, and software that enhance safety, efficiency, and overall patient outcomes in medical environments.
Stryker Corps business model focuses on innovation in medical technologies and devices, specializing in areas such as orthopedics, surgical equipment, and neurotechnology, to enhance patient care and improve outcomes in the healthcare industry.
West Pharmaceutical Services Inc Share Performance
+22.52%
This Year
West Pharmaceutical Services Inc
Profile
West Pharmaceutical Services Inc operates as a global manufacturer and supplier of innovative packaging and delivery systems for the pharmaceutical and biotech sectors. Their business model focuses on providing comprehensive solutions, including drug administration systems and customer support, to ensure safe and efficient delivery of medications to patients.
Sources:
Milestone Scientific Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Milestone Scientific Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
